Gaviscon recall: Superpotent
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
Why was Gaviscon recalled?
Superpotent Drug: high out-of-specification result for magnesium.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 5J69A, Exp 02/19; 6GF2A, 6GF3A, Exp 08/19
- Product
- Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg, 100-count bottles, Distributed by: GlaxoSmithKline Consumer Healthcare, L.P., Moon Twp, PA 15108, UPC 3 0088-1175-47 8.
- Recalling firm
- Sanofi-Aventis U.S. LLC
- Quantity
- 2980 bottles
- Distribution
- Nationwide in the USA, Puerto Rico, and the United Kingdom.
- Recall date
- July 5, 2017
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)